1. The impact of depressive symptoms on health value in patients with gynecologic cancer: A comparison with physical symptoms and performance status
- Author
-
Hyemin Yeo, Ye Lee Yu, and Sokbom Kang
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Genital Neoplasms, Female ,Visual analogue scale ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Surveys and Questionnaires ,Internal medicine ,Gynecologic cancer ,Humans ,Medicine ,In patient ,Patient Reported Outcome Measures ,Prospective Studies ,Depressive symptoms ,Depression (differential diagnoses) ,Aged ,Performance status ,Depression ,business.industry ,Obstetrics and Gynecology ,Cancer ,Middle Aged ,medicine.disease ,Cross-Sectional Studies ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Quality of Life ,Female ,business - Abstract
The importance of managing depressive symptoms is frequently underestimated in the clinic. In this study, the effects of depressive symptoms on health utility value (HUV) in gynecologic cancer patients are evaluated. In addition, the effects were compared with those of performance status and physical symptoms.Patient-reported outcome data from 274 gynecologic cancer patients were prospectively collected. HUV was measured using the 3-level version of the EuroQoL 5-dimension descriptive system (EQ-5D-3L) and the EuroQoL visual analog scale (EQ-VAS). The Patient Health Questionnaire-9 (PHQ-9) was used to measure the severity of depressive symptoms. The impact of depressive symptoms on HUV was analyzed using the generalized linear model.Moderate-severe depressive symptoms were significantly associated with a decrease in HUV in gynecologic cancer patients (p 0.0001 for the EQ-5D-3L and EQ-VAS). Severe fatigue and severe pain were also associated with a decrease in HUV (p = 0.018 and p 0.0001 for the EQ-5D-3L and EQ-VAS; p 0.0001 for the EQ-5D-3L, respectively), and the effect sizes were comparable to that of moderate-severe depressive symptoms. In addition to the patients with moderate-severe depressive symptoms, the patients with mild depressive symptoms also experienced a significant decrease in HUV (p 0.0001 for the EQ-5D-3L and EQ-VAS). The effect size for mild depressive symptoms was comparable to those for mild fatigue or mild pain.Even mild depressive symptoms may significantly compromise HUV in gynecologic cancer patients, and the effect is comparable to that of performance status or physical symptoms. Gynecologic oncologists should put more effort into properly preventing, detecting, and managing depressive symptoms.
- Published
- 2020